Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05987319 · ClinicalTrials.gov registry record · NA
Feasibility Study to Collect and Assess Safety Data for a Radiofrequency Microneedling Device for Electrocoagulation and Hemostasis of Soft Tissues for Dermatologic Conditions
A NA study of Wrinkle and Fine Lines, sponsored by Cynosure.
- Recruiting
- Registry status
- NA
- Development phase
- 20
- Enrollment target
- 1
- Study location
NCT05987319: Recruiting NA study of Wrinkle and Fine Lines, sponsored by Cynosure.
NCT05987319 is a NA study of Wrinkle and Fine Lines that is actively recruiting participants, run by Cynosure. The registered enrollment target is 20 participants, below the 119-participant average among 25 other Wrinkle trials with a reported enrollment target (83% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05987319, a NA study of Wrinkle and Fine Lines, is actively recruiting participants, sponsored by Cynosure.
- RECRUITING
- Registry status
- NA
- Development phase
- 20 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of the Potenza device used in this study is to collect clinical data for dermatologic conditions in which electrocoagulation and hemostasis is a viable mechanism for means of improvement.
Conditions Studied
Interventions
- DEVICE RadioFrequency Microneedling Device
Study Locations (1)
Massachusetts
- Cynosure, Inc. - Westford
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2023-07-24 |
| Est. Completion | 2024-08 |
| Phase | NA |
What NCT05987319 shows while recruiting
NCT05987319 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 20 participants, a relatively small participant target, below the 119-participant average among 25 other Wrinkle trials with a reported enrollment target (83% lower).
The record links to 8 conditions, with Wrinkle appearing as the primary indexed condition, and to 1 intervention - of which RadioFrequency Microneedling Device is the first listed.
NCT05987319 reports a single indexed study location in Massachusetts.
Frequently Asked Questions
What is clinical trial NCT05987319 about?
NCT05987319 is a clinical study titled "Feasibility Study to Collect and Assess Safety Data for a Radiofrequency Microneedling Device for Electrocoagulation and Hemostasis of Soft Tissues for Dermatologic Conditions". The goal of the Potenza device used in this study is to collect clinical data for dermatologic conditions in which electrocoagulation and hemostasis is a viable mechanism for means of improvement.
What is the current status of trial NCT05987319?
This trial is currently recruiting. It is a NA study. The enrollment target is 20 participants. The study started on 2023-07-24. Estimated completion is 2024-08.
What conditions does trial NCT05987319 study?
This clinical trial studies the following conditions: Wrinkle, Fine Lines, Acne Scars, Crepey Skin, Active Acne.
What interventions are being tested in trial NCT05987319?
The interventions under investigation include: RadioFrequency Microneedling Device (DEVICE).
Who is sponsoring clinical trial NCT05987319?
This trial is sponsored by Cynosure, which has 49 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05987319 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Wrinkle
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05987319's enrollment target sits among peer trials
20 22nd of 25 higher than 4 of 25 other Wrinkle trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Wrinkle trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
The Effects of Topical Almond Oil and Tretinoin on Facial Wrinkles
RECRUITING · NA
-
AVAVA MIRIA General Use
RECRUITING · NA
-
The Effects of Almond on Facial Skin Collagen and Wrinkles
RECRUITING · NA
-
A Prospective Controlled Study to Evaluate the Safety and Effectiveness of Thermage® FLX Radiofrequency Treatment
RECRUITING · NA
-
Clinical Study to Evaluate the Safety and Efficacy of Candela Technology
ACTIVE NOT RECRUITING · NA
-
AV-23-001 AVAVA MIRIA Pilot Study
ACTIVE NOT RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00573339 · 20 participants
Cardiac Magnetic Resonance Imaging (MRI) Normal Reference Control Group Testing
- NCT00692939 · 20 participants · Phase 1
Autologous Stem Cell Transplantation for Crohn's Disease
- NCT00967785 · 20 participants · Phase 1
A Phase I Study of Mozobil in the Treatment of Patients With WHIMS
- NCT01406691 · 20 participants · Phase 4
Light Flashes to Treat Delayed Sleep Phase Disorder (DSPD)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI